Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

588
Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
588
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

121
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
121
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

491
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
491
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

896
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
896
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

360
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
360

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of an in-vitro test protocol using a three-dimensional human buccal oral mucosal model to assess the oral medical devices.

Toxicology in vitro : an international journal published in association with BIBRA·2026
Same author

National Trends in Healthcare Quality in Korea: A Multidimensional Assessment Using OECD Health Care Quality Indicators (2008-2023).

Journal of preventive medicine and public health = Yebang Uihakhoe chi·2026
Same author

A Standard Herbal Formula, CGAC, Attenuates Bone Loss by Normalizing Low-Bone Turnover Stagnation in an Orchiectomy-Induced Mouse Model.

Pharmaceuticals (Basel, Switzerland)·2026
Same author

Nationwide population based epidemiological characteristics of complex regional pain syndrome in South Korea.

Scientific reports·2026
Same author

Sex differences in patients hospitalized for repair of intact abdominal aortic aneurysms in 11 high-income countries: A cross-sectional cohort study.

Journal of vascular surgery·2026
Same author

[Surveillance Report of Imported SARS-CoV-2 Variants at Incheon International Airport and Incheon Port (February 15, 2021-March 2023)].

Jugan geon-gang gwa jilbyeong·2025
Same journal

Automated lung cancer classification using intensity-driven RoI selection and transfer learning.

BMC medical informatics and decision making·2026
Same journal

Generating Alzheimer's narratives using large language models.

BMC medical informatics and decision making·2026
Same journal

Leveraging human-centered AI for clinical decision-making: a transparent, accurate rule extractor using non-dominated sorting genetic algorithm.

BMC medical informatics and decision making·2026
Same journal

Augmenting medical data interpretation with Large Language Models (LLMs): a comparative analysis of patient empowerment, information processing, and technology acceptance.

BMC medical informatics and decision making·2026
Same journal

A multicenter machine learning model for predicting ICU mortality in mechanically ventilated patients: development and external validation.

BMC medical informatics and decision making·2026
Same journal

An explainable machine learning model for predicting high phosphorus risk in patients on maintenance hemodialysis: a multicenter retrospective study.

BMC medical informatics and decision making·2026
See all related articles

Related Experiment Video

Updated: May 5, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K

The predictability of claim-data-based comorbidity-adjusted models could be improved by using medication data.

Ji Hwan Bang, Soo-Hee Hwang, Eun-Jung Lee

  • 1Department of Health Policy and Management, Seoul National University College of Medicine, 103 Daehak-ro, Jongno-gu, Seoul 110-799, Korea. yoonkim@snu.ac.kr.

BMC Medical Informatics and Decision Making
|November 22, 2013
PubMed
Summary
This summary is machine-generated.

Integrating medication data to infer comorbidities can slightly improve the predictability of Charlson index and Elixhauser comorbidity measures for in-hospital mortality prediction models.

More Related Videos

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

Related Experiment Videos

Last Updated: May 5, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.4K
Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

8.4K
A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.0K

Area of Science:

  • Health Informatics
  • Clinical Epidemiology
  • Predictive Modeling

Background:

  • Claim-data-based comorbidity indices like Charlson and Elixhauser are widely used.
  • There is a need to enhance the predictive accuracy of these comorbidity models.
  • Medication data offers potential for identifying unrecorded comorbidities.

Purpose of the Study:

  • To improve the predictability of comorbidity-adjusted models using medication data.
  • To estimate omitted comorbidities in claim data by leveraging medication information.
  • To evaluate the impact of inferred comorbidities on the performance of Charlson and Elixhauser indices.

Main Methods:

  • Selected 12 major non-malignant diseases causing in-hospital mortality in large South Korean hospitals (2008).
  • Constructed prediction models for in-hospital mortality using Charlson index and Elixhauser comorbidity measures.
  • Inferred missed comorbidities from medication data and built enhanced prediction models, comparing their c-statistics.

Main Results:

  • Analyzed 247,712 admission cases; used 55 generic drugs for Charlson and 106 for Elixhauser comorbidities.
  • Initial model c-statistics ranged from 0.633-0.882 (Charlson) and 0.699-0.917 (Elixhauser).
  • Inclusion of inferred comorbidities improved predictability in 9/12 Charlson models and all Elixhauser models, though improvements were modest.

Conclusions:

  • Incorporating comorbidities inferred from medication data can enhance prediction models based on Charlson index or Elixhauser comorbidity measures.
  • This approach offers a method to refine existing comorbidity assessment tools.
  • Further research may explore broader applications of medication data in clinical prediction.